AHA: Small Increase in Cardiac Stress Testing 2005 to 2012

Share this content:
AHA: Small Increase in Cardiac Stress Testing 2005 to 2012
AHA: Small Increase in Cardiac Stress Testing 2005 to 2012

WEDNESDAY, Nov. 16, 2016 (HealthDay News) -- Among a nationally representative cohort of commercially insured patients there was a small increase in the rate of cardiac stress testing from 2005 to 2012, according to a study published online Nov. 15 in JAMA Cardiology. The research was published to coincide with the annual meeting of the American Heart Association, held from Nov. 12 to 16 in New Orleans.

Vinay Kini, M.D., from the Hospital of the University of Pennsylvania in Philadelphia, and colleagues examined trends in rates of cardiac stress testing in a serial cross-sectional study using administrative claims from members aged 25 to 64 years belonging to a national managed care company from 2005 to 2012.

The researchers found that from 2005 to 2012 there was a 3.0 percent increase in the rates of cardiac stress testing (P = 0.01 for linear trend). From 2005 to 2012 there was a 14.9 percent decrease in the use of nuclear single-photon emission computed tomography (P = 0.03). There were increases in use of stress echocardiography (27.8 percent from 2005 to 2012; P < 0.001), exercise electrocardiography (12.5 percent from 2005 to 2012; P < 0.001), and other stress testing modalities (65.5 percent from 2006 to 2012; P < 0.001).

"Our findings suggest that observed trends in the use of cardiac stress testing may have been driven more by unique characteristics of populations and health systems than national efforts to reduce the overuse of testing," the authors write.

Full Text
More Information

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Approves Zejula for Certain Female Cancers

FDA Approves Zejula for Certain Female Cancers

PARP inhibitor may help fight tumors affecting the ovaries, fallopian tubes, or peritoneum

USPSTF: Evidence Lacking for Celiac Dz Screen in Asymptomatic

USPSTF: Evidence Lacking for Celiac Dz Screen in ...

Insufficient evidence for weighing benefits, harms of screening for celiac disease in asymptomatic

Lap, Abdominal Hysterectomy Equal for Early Endometrial CA

Lap, Abdominal Hysterectomy Equal for Early Endometrial CA

Equivalent disease-free survival at 4.5 years for stage I endometrial cancer with TAH, TLH

is free, fast, and customized just for you!

Already a member?

Sign In Now »